Sandra Vedrick | Director, IR |
George Tidmarsh | President, CEO, Secretary & Director |
Dennis Mulroy | CFO |
Yatin Suneja | SunTrust Robinson Humphrey |
Gbolahan Amusa | Chardan Capital Markets |
Philip Nadeau | Cowen and Company |
Kyung Yang | Jefferies |
Welcome to the La Jolla Pharmaceutical Company Second Quarter 2018 Financial Results Call. [Operator Instructions].
As a reminder, today's conference is being recorded. On today's call, La Jolla will be making forward-looking statements. These statements relate to expectations regarding future events or future results of operations and are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated.